Plus Therapeutics reports Q1 2026 financial results and corporate updates
Filed May 15, 2026 · Period ending May 15, 2026 · ~1 min read
Key Changes
-
medium
Plus Therapeutics disclosed financial results for the quarter ended March 31, 2026, along with unspecified corporate updates via press release.
Item 2.02 verify on EDGAR → -
medium
The 8-K filing references a press release (Exhibit 99.1) containing the actual financial figures and operational details, which are not included in the filing body.
Item 9.01 verify on EDGAR →
See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.
Partner
Trade PSTV commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 8, 2026 5:41 AM